Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients With Advanced NMSC

This current registry study will analyze real-world data to address questions about disease characteristics and treatment patterns in NMSC patients based on the European NMSC-Registry. The overall objective is to describe characteristics, management and treatment outcomes for patients presenting with advanced NMSC (cSCC/BCC) or HR-cSCC in routine clinical practice, independent of treatments used across different European regions.

Inclusion Criteria:Patients aged ≥18 years at index datePatients documented in the European NMSC-registry fulfilling EMR quality standardPatients with resected HR-cSCC (Cohort 1) receiving only postoperative radiotherapy or watchful waiting OR Patients with advanced cSCC who are not candidates for curative surgery/radiation in routine clinical practice (Cohort 2) OR Patients with advanced BCC who are not candidates for curative surgery/radiation in routine clinical practice (Cohort 3)Exclusion Criteria:1. Patients receiving treatment within a clinical trial.